Related Experiment Video
Updated: Aug 10, 2026
07:43
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
Management of Brain Metastases
Suriya A. Jeyapalan1, Tracy Batchelor
1Brain Tumor Center, Cox 315, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. tbatchelor@partners.org
Current Treatment Options in Neurology
|May 26, 2004
Summary
Treatment for brain metastases is evolving with neurosurgery and stereotactic radiosurgery, but consensus on the best strategy remains elusive due to patient heterogeneity. Class I evidence guides some decisions, aiming to improve survival duration and quality.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Oncology
Background:
- Neurosurgery and stereotactic radiosurgery have advanced treatment options for brain metastases.
- Despite clinical trials, a uniform treatment consensus is lacking for brain metastases patients.
Purpose of the Study:
- To review current treatment strategies for brain metastases.
- To highlight the challenges in establishing a consensus due to patient heterogeneity.
- To identify areas with Class I evidence guiding treatment decisions.
Main Methods:
- Review of randomized clinical trials and uncontrolled studies on brain metastases management.
- Analysis of patient factors influencing treatment strategy selection (functional status, cancer type, systemic disease, metastasis characteristics).
Main Results:
- Heterogeneity in patient populations (functional status, cancer type, disease control, metastasis number/location) complicates consensus.
- Class I evidence supports specific approaches in certain clinical scenarios.
- Primary goals of treatment are improved survival duration and quality of life.
Conclusions:
- Optimal treatment for brain metastases requires individualized approaches due to significant patient heterogeneity.
- While consensus is difficult, existing evidence guides management in specific situations.
- Long-term survival remains rare for patients diagnosed with brain metastases.
